Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology.
暂无分享,去创建一个
[1] A. Spock,et al. Bacteremia in Patients with Cystic Fibrosis , 1980, Clinical pediatrics.
[2] M. Corey,et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. , 1984, The Journal of pediatrics.
[3] Rosenstein Bj,et al. Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis. , 1980 .
[4] D. Dearborn,et al. In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments , 1983, Infection and immunity.
[5] R. Baltimore,et al. Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis. , 1982, Helvetica paediatrica acta.
[6] J. Govan,et al. Typing of Pseudomonas cepacia by bacteriocin susceptibility and production , 1985, Journal of clinical microbiology.
[7] H. Greenlee,et al. Pseudomonas cepacia strains isolated from water reservoirs of unheated nebulizers , 1976, Journal of clinical microbiology.
[8] N. Palleroni,et al. Pseudomonas cepacia sp. nov., nom. rev. , 1981 .
[9] M. Favero,et al. Morphological, biochemical, and growth characteristics of pseudomonas cepacia from distilled water. , 1973, Applied microbiology.
[10] E. J. Benner,et al. Necrotizing pneumonicitis due to the pseudomonad "eugonic oxidizer--group I". , 1968, The New England journal of medicine.
[11] J. Pennington,et al. Evaluation of a new polyvalent Pseudomonas vaccine in respiratory infections , 1979, Infection and immunity.
[12] V. Jonsson. Proposal of a new species Pseudomonas kingii1 , 1970 .
[13] M. Thomassen,et al. Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients. , 1985, Diagnostic microbiology and infectious disease.
[14] G. Keusch,et al. Association of Pseudomonas cepacia with chronic granulomatous disease , 1975, Journal of clinical microbiology.
[15] S. Shapiro,et al. Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. , 1981, Annals of internal medicine.
[16] C. Nord,et al. Synergistic Effect of Combinations of Sulfamethoxazole, Trimethoprim, and Colistin Against Pseudomonas maltophilia and Pseudomonas cepacia , 1974, Antimicrobial Agents and Chemotherapy.
[17] D. Bassett,et al. Foot lesions associated with Pseudomonas cepacia. , 1971, Lancet.
[18] R. Kaslow,et al. Aqueous quaternary ammonium antiseptics and disinfectants. Use and misuse. , 1976, JAMA.
[19] P. Gilligan,et al. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis , 1985, Journal of clinical microbiology.
[20] J. Pennington,et al. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection , 1983, Infection and immunity.
[21] A. Chakrabarty,et al. Detoxification of 2,4,5-trichlorophenoxyacetic acid from contaminated soil by Pseudomonas cepacia , 1983, Applied and environmental microbiology.
[22] R. Berkelman,et al. Pseudomonas cepacia peritonitis associated with contamination of automatic peritoneal dialysis machines. , 1982, Annals of internal medicine.
[23] G. Pulverer,et al. 4,9-Dihydroxyphenazine-1,6-dicarboxylic acid dimethylester and the 'missing link' in phenazine biosynthesis. , 1978, Journal of general microbiology.
[24] J. Klinger,et al. Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis. , 1985, The Journal of antimicrobial chemotherapy.
[25] H. Monteil,et al. O and H serotyping of Pseudomonas cepacia , 1983, Journal of clinical microbiology.
[26] A. Vidaver,et al. Bacteriocin, plasmid and pectolytic diversity in Pseudomonas cepacia of clinical and plant origin. , 1979, Journal of general microbiology.
[27] D. Speller,et al. Hospital infection by Pseudomonas cepacia. , 1971, Lancet.
[28] D. Woods,et al. Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis , 1984, Journal of clinical microbiology.
[29] G. Gilardi. Antimicrobial susceptibility as a diagnostic aid in the identification of nonfermenting gram-negative bacteria. , 1971, Applied microbiology.
[30] R. Wenzel,et al. Pseudomonas cepacia: implications and control of epidemic nosocomial colonization. , 1981, Reviews of infectious diseases.
[31] J. Klinger,et al. In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis , 1984, Antimicrobial Agents and Chemotherapy.
[32] J. A. Bass,et al. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. , 2015, The American review of respiratory disease.
[33] R. Stern,et al. Ceftazidime therapy in patients with cystic fibrosis and multiply-drug-resistant pseudomonas. , 1985, The American journal of medicine.
[34] S. Mitsuhashi,et al. Purification and properties of a new beta-lactamase from Pseudomonas cepacia , 1980, Antimicrobial Agents and Chemotherapy.
[35] M. Corey,et al. Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981. , 1984, The Journal of infectious diseases.
[36] H. Heymann,et al. Fourteen-year survival of Pseudomonas cepacia in a salts solution preserved with benzalkonium chloride , 1979, Applied and environmental microbiology.
[37] R. Klein,et al. Cervical osteomyelitis caused by Pseudomonas cepacia in an intravenous-drug abuser , 1985, Journal of clinical microbiology.
[38] T. Lessie,et al. Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source , 1979, Journal of bacteriology.
[39] H. Shwachman,et al. STUDIES IN CYSTIC FIBROSIS A Report on Sixty-Five Patients over 17 Years of Age , 1965 .
[40] C. Darby. Treating Pseudomonas cepacia meningitis with trimethoprim-sulfamethoxazole. , 1976, American journal of diseases of children.
[41] V. M. Young,et al. In Vitro Susceptibility of Pseudomonas cepacia and Pseudomonas maltophilia to Trimethoprim and Trimethoprim-Sulfamethoxazole , 1975, Antimicrobial Agents and Chemotherapy.
[42] M. Miller,et al. Recurrent pneumonitis due to Pseudomonas cepacia. An unexpected phagocyte dysfunction. , 1975, The Western journal of medicine.
[43] J. Rahal,et al. Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts. , 1975, The American journal of medicine.
[44] W. Schaffner,et al. Contaminated aqueous benzalkonium chloride. An unnecessary hospital infection hazard. , 1976, JAMA.
[45] B. J. Wu,et al. Selective medium for Pseudomonas cepacia containing 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan and polymyxin B sulfate , 1984, Applied and environmental microbiology.
[46] P. Gilligan,et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. , 1985, The Journal of pediatrics.
[47] E. Yabuuchi,et al. [Serological classification of Pseudomonas cepacia]. , 1984, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.
[48] P. Vos,et al. Ribosomal ribonucleic acid cistron similarities of phytopathogenic Pseudomonas species , 1985 .
[49] M. Doudoroff,et al. Nucleic Acid Homologies in the Genus Pseudomonas , 1973 .
[50] H. Levison,et al. Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis. , 1985, Pediatric infectious disease.
[51] W. H. Burkholder. Sour skin, a bacterial rot of Onion bulbs. , 1950 .
[52] M. Nahata,et al. Bacterial contamination of aerosol solutions used to treat cystic fibrosis. , 1982, American journal of hospital pharmacy.
[53] D. Grant,et al. Pseudomonas cepacia as contaminant and infective agent. , 1983, The Journal of hospital infection.
[54] M D Reed,et al. Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response. , 1983, The Journal of antimicrobial chemotherapy.
[55] J. Klinger,et al. In-vitro activity of ciprofioxacin and other antibacterial agents against Pseudonwnas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients , 1985 .
[56] J. Sanford,et al. Bacterial contamination of aerosols. , 1973, Archives of internal medicine.
[57] J. Klinger,et al. PSEUDOMONAS CEPACIA BACTEREMIA IN CYSTIC FIBROSIS , 1984, Pediatric Research.
[58] M. Corey,et al. Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin. , 1982, The Journal of pediatrics.
[59] O. Sieber,et al. PSEUDOMONAS CEPACIA PNEUMONIA IN A CHILD WITH CHRONIC GRANULOMATOUS DISEASE AND SELECTIVE IgA DEFICIENCY , 1976, Acta paediatrica Scandinavica.
[60] H. Levison,et al. Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis , 1983, Pediatric infectious disease.
[61] A. Steere,et al. Pseudomonas species bacteremia caused by contaminated normal human serum albumin. , 1977, The Journal of infectious diseases.
[62] H. Levison,et al. Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. , 1983, The Journal of antimicrobial chemotherapy.
[63] J. Richards,et al. Pseudomonas cepacia resistance to antibacterials. , 1979, Journal of pharmaceutical sciences.
[64] R. Stern,et al. Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis. , 1985, Reviews of infectious diseases.